hard not to compare ISA executives to ones at Quest Pharma, QPT, down the road up in Edmonton.  Quest announced today that they have acquired immunoglobulin technology from an American firm to strengthen it's combination therapy approach for the treatment of cancer.  It's share price sits at .06 cents, hit a low of .03 in the past.  It's future looks promising,  THEIR IS HOPE FOR A FUTURE.  The salary of it's execs. , a grand total of $400, 906. The CEO, director--194,000 ,     the CFO, director $  70,906,  the Vice-president, $136,000.  Over at ISA , the execs. barely get by on $1, 158, 232.   Dr. Foster--CEO, $362, 930, Dennis Bourgeault - CFO. $232, 058,  Dr. Aspelt , COO, $230,277 ,  Dr. Freitag, Chief Science, $165, 436 , Mr. Huzienga, Transplant Coordinator, $167, 531 .   Quest has SUCCESSFULLY raised private placements recently and their coffers are full, to move forward .  ISA , is mired in debt excrement,  owing Paladin over $1, 700, 000 for drug purchase, the hundreds of thousands for the arbitration hearings at the International Chamber of Commerce, and THERE IS NO MONEY COMING IN,  like the old saying goes, PAY YOURSELF FIRST!!!!!!  WOOF, WOOF!  ZOOM! ZOOM! my little porsche...............